Mobile App for Distress Reduction in Young Women with Breast Cancer
Mighty Pro Application
Breast Diseases+3
+ Breast Neoplasms
+ Neoplasms
Supportive Care Study
Summary
Study start date: February 1, 2026
Actual date on which the first participant was enrolled.This clinical trial focuses on young women aged 18 to 45 who have been diagnosed with breast cancer and are experiencing significant distress, as indicated by a distress score of 4 or higher on a specific scale. The study aims to explore whether a mobile app called Mighty Pro can help reduce cancer-related stress through social connections and educational resources. This could be important because managing stress is a crucial aspect of the overall treatment and well-being of young women with breast cancer. In this study, participants use the Mighty Pro app, which is designed to provide social support and educational content. The trial is conducted at the Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Researchers will monitor how effectively the app reduces distress levels in participants. The study is organized into two stages and will evaluate both the feasibility of using this app and its effectiveness in offering emotional support. The goal is to see if this digital tool can be a beneficial addition to the supportive care for young women facing breast cancer.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.120 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location